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Summary
A multidisciplinary Tier 3 weight management service in primary care recruited
patients with a body mass index ≥40 kg·m−2, or 30 kg·m−2 with obesity-related
co-morbidity to a 1-year programme. A cohort of 230 participants was recruited
and evaluated using the National Obesity Observatory Standard Evaluation
Framework. The primary outcome was weight loss of at least 5% of baseline
weight at 12 months. Diet was assessed using the two-item food frequency
questionnaire, activity using the General Practice Physical Activity questionnaire
and quality of life using the EuroQol-5D-5L questionnaire. A focus group
explored the participants’ experiences. Baseline mean weight was 124.4 kg and
mean body mass index was 44.1 kg·m−2. A total of 102 participants achieved 5%
weight loss at 12 months. The mean weight loss was 10.2 kg among the 117
participants who completed the 12-month programme. Baseline observation
carried forward analysis gave a mean weight loss of 5.9 kg at 12 months. Fruit
and vegetable intake, activity level and quality of life all improved. The dropout
rate was 14.3% at 6 months and 45.1% at 1 year. Focus group participants
described high levels of satisfaction. It was possible to deliver a Tier 3 weight
management service for obese patients with complex co-morbidity in a primary
care setting with a full multidisciplinary team, which obtained good health out-
comes compared with existing services.
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Background
Obesity is an increasing problem in the UK, where the
obesity rate is the highest in Europe (1). The Department of
Health’s ‘Call to action on obesity’ in England (2) set a target
to reduce the prevalence of adult obesity by 2020, and
acknowledged the need to provide clinical services for obese
adults in addition to public health preventative interven-
tions. A recent review of effective UK weight management
services for adults (3) suggested that self-referral to commer-
cial agencies was a reasonable first step. The review also
cited evidence that a primary care-based weight manage-
ment service, the Counterweight programme (4), delivered
by trained practice nurses or dietitians was effective in
maintaining weight loss of over 5 kg for up to 2 years in
30–40% of attenders. It highlighted the lack of evidence of
effectiveness of services for severely obese individuals (body
mass index [BMI] ≥35 kg·m−2) with 12 months or longer
follow-up, and suggested that complicated or resistant
obesity should be referred to a secondary care-based service.
Patients with a BMI of at least 35 kg·m−2 and complex
co-morbidity may be suitable for medical interventions
including pharmacotherapy, low-energy liquid diets
(LELDs) and bariatric surgery, which has been shown to be
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highly cost-effective for appropriately selected individuals.
The National Health Service (NHS) Commissioning Board
issued guidance on clinical commissioning for complex and
specialized obesity surgery (5), which includes a four tier
model for managing obesity, similar to the National
Obesity Forum model (Fig. 1). The British Obesity and
Metabolic Surgery Society sponsored a National Institute
for Clinical Excellence (NICE) accredited process, run by
the Royal College of Surgeons to provide a commissioning
guide for weight assessment and management clinics which
gives detailed guidance on Tier 3 and Tier 4 services, and
a pertinent section on evaluation recommending the
National Obesity Observatory Standard Evaluation Frame-
work (6). Primary care is arguably an ideal place to provide
weight management services, as most health service contact
with obese people occurs there (2,7,8), and people may be
more responsive to advice when it is linked to health-
related issues (9). The National Service Frameworks for
both coronary heart disease (10) and diabetes (11), and
NICE guidelines (12–16) emphasize the role of primary
care in management of obesity.
NHS Norfolk Primary Care Trust and the North Norfolk
Clinical Commissioning Group (NNCCG) identified
obesity as a priority in 2011. A review of the Norfolk
obesity care pathway identified a lack of Tier 3 specialist
weight management services in the county. North Norfolk
is a rural area with an elderly population, and poor public
transport, and the NNCCG wished to provide an accessible
service. In 2011, the NHS East of England Innovation Fund
awarded funds to the Fakenham medical practice to
develop a Tier 3 multidisciplinary team service in primary
care.
Description of the service
The Fakenham weight management service (FWMS) pro-
vides Tier 3 services. It was developed from an existing
service at the Fakenham medical practice, which had won
the National Obesity Forum award for excellence in weight
management in 2010. It was modelled on the Rotherham
Institute of Obesity (RIO) service (17), following NICE
guidelines (12), and the National Obesity Forum toolkit
(18). FWMS aimed to deliver evidence-based interventions
including medical assessment, motivational interviewing to
support behaviour change (19–21), dietary and activity
advice, psychological therapies, drug therapy with orlistat,
medically supervised LELDs (6,12,22) and assessment for
suitability for bariatric surgery using the NHS East of
England criteria (aged 18–60 years, BMI ≥40 kg·m−2, with
Figure 1 Tiered model of services.
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either diabetes or severe obstructive sleep apnoea, and
having undergone a 6-month intensive weight-loss
programme).
The service aimed to facilitate weight loss by implement-
ing progressive and sustainable lifestyle changes, based
on individually agreed goals over a 1-year programme. This
was delivered by individual monthly appointments with
obesity specialist nurses (OSNs) using a dietary diary
as a basis for agreeing specific changes, accompanied by a
structured educational programme (Fig. 2). Participants
were considered for pharmacotherapy, LELDs or bariatric
surgery if clinically appropriate. Psychological therapies
offered included cognitive behaviour therapy, neuroli-
nguistic programming, emotional freedom therapy, clinical
hypnosis, solution focused therapy, transactional analysis,
psychodynamic therapy and cognitive analytical therapy.
In addition to the 1 year service commissioned by
NNCCG, neighbouring Clinical Commissioning Groups
(CCGs) also referred 17 patients via the individual funding
request (IFR) mechanism. These IFR patients met the same
entry criteria, and were given the same intervention but
over a 6-month period. The number of visits ranged from
nine to 15 visits for the IFR programme over 6 months
compared with a range of 10–15 visits for the 1-year
programme.
The programme was provided by a lead general practi-
tioner with additional training as a bariatric physician (spe-
cialist certificate of obesity professional education), OSNs,
dietitian, psychological therapist, exercise professional,
health trainer and supported by a consultant endocrinolo-
gist and public health consultant. The OSNs were trained
in motivational interviewing techniques (19–21), and the
psychological therapist had extensive experience in
working with clients with obesity and eating disorders. The
clinical core steering group also included two patient rep-
resentatives from the weight management programme, and
a representative from the Fakenham Patient Participation
Group who was responsible for checking that the patient
information literature was easy to understand.
The primary clinical outcome measure for evaluation of
the service was 5% weight loss at 12 months, as this has
been shown to produce definite health benefits (23–26),
with the aim to achieve this in 50% of participants at 6
months.
Referrals were accepted from General Practitioners (GPs)
or practice nurses. Entry criteria were: age over 18 years,
BMI ≥40 kg·m−2, or BMI ≥30 kg·m−2 with obesity-related
co-morbidity and/or waist circumference ≥102 cm in men
or ≥88 cm in women. Exclusion criteria were: pregnancy,
severe eating disorder, poor motivation identified by a
motivational questionnaire (18) or failure to respond to an
invitation to contact the service.
All participants were asked to sign a contract, which
committed them to attending regularly, and allowed the
FWMS to contact their own GP for up to 2 years after
discharge to obtain data on weight maintenance. The pro-
gramme involved an initial information-gathering inter-
view coupled with motivational assessment (Fig. 2). The
second visit included a medical assessment, followed by a
discussion on the health risks of obesity and the health
benefits of losing weight. The daily energy requirement of
each participant was calculated using the Schofield equa-
tion, and a 600 kcal daily deficit was recommended, aiming
for a weight loss of 0.5–1 kg a week. An initial 5% weight
loss goal was agreed, and this was modified once they
reached this target to aim for a further progressive 5%
weight loss targets. A number of those assessed declined to
enrol after the assessment visits, and a few patients were
deemed medically unsuitable for a primary care-based
service and were referred to the local endocrinology service
(Fig. 3).
Once enrolled, participants attended regular monthly
OSN consultations, using dietary diaries and a structured
but flexible individual diet and activity education pro-
gramme. The areas covered are described in Fig. 2. All
participants were screened for obstructive sleep apnoea
using the Epworth score, neck circumference and clinical
history, and were referred for sleep studies as appropriate.
Weight was measured using specialist digital bariatric
scales which were regularly calibrated. Baseline blood tests
were fasting glucose and lipids, liver function and thyroid
function, and HbA1c if diabetic.
Participants with complex medical problems were all
seen by the physician either at the second assessment visit
or subsequently. The physician’s role was to assess and
manage complex comorbidities, and to detect others such
as endocrine problems, depression or sleep apnoea. The
physician communicated with the participants’ own GP or
the secondary care specialists when medically appropriate.
A medical opinion on fitness to exercise was also required
for some participants. Orlistat was prescribed and moni-
tored by FWMS, but all other medications were prescribed
by participants’ own GP. The FWMS physician was also
involved in the assessment and monitoring of those on a
LELD, in accordance with an agreed protocol with local
endocrinologists.
Every participant was discussed initially at the weekly
multidisciplinary team meeting, and appropriate referrals
made to other team members. Any pre-bariatric surgery
participants saw the physician and psychological therapist
on at least two occasions, and all other participants were
referred from the multidisciplinary team meetings to the
physician or psychological therapist as required.
As part of the programme, nine patients used LELDs,
and 36 patients were prescribed orlistat. Four patients were
referred to the endocrinologist for investigation, and eight
were referred for investigation of possible obstructive sleep
apnoea.
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The exercise professional provided both individual and
small group sessions at the on-site gym, and there was also
a 12-week exercise referral scheme using local gyms. The
gym was unavailable till January 2012, 5 months after the
start of the programme. A post-discharge patient-led
support group was set up in 2012 and met at monthly
intervals with open access for all those attending the pro-
gramme.
The participants were discharged if they failed to attend
twice with any of the therapists.
Aims
The service was evaluated using the National Obesity
Observatory Standard Evaluation Framework (NOO SEF)
(27–29). The primary outcome measure was >5% weight
Figure 3 Patient flow diagram.
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loss at 1 year, with the aim to reach this target within 6
months in 50% of the participants.
Methods
In 2009, England’s National Obesity Observatory set out a
list of essential and desirable criteria that should be col-
lected as part of any evaluation of a weight management
intervention to standardize core information, to encourage
the use of evidence-based tools and to allow comparisons
between different interventions. Its value was recognized by
the Department of Health and highlighted in its ‘call to
action on obesity’ (2), and in commissioning guidelines
(5,6).
This service evaluation had a cohort design, following all
230 participants enrolled sequentially from August 2011 to
August 2012 (Fig. 3), and describing changes in their
weight and other health indicators, as defined in the NOO
SEF (27–29). At baseline, years of education was recorded
as a socioeconomic indicator. Nineteen years of education
or above corresponds to first degree or National Vocational
Qualification (NVQ) level 4 and 5, which is associated with
higher socioeconomic status (27). The following data on
each participant was recorded at baseline, 3, 6, 9 and
12 months: height, weight, BMI, waist circumference,
dietary intake, (two-item food frequency questionnaire
(30,31), physical activity levels [General Practice Physical
Activity Questionnaire (GPPAQ) (32)] and quality of life
(EQ-5D-5L questionnaire (33)).
The two-item food frequency questionnaire was chosen as
fruit and vegetable intake has been shown to be a good
proxy marker for a healthy diet (29–31). The GPPAQ was
chosen as it is widely used in general practice and is recog-
nized and recommended by NICE (12,16), with the proviso
that it is not a direct measure of activity, and that it may not
be the most sensitive instrument to measure change of
activity in those with severe limitations on increasing activ-
ity. The EQ-5D-5L (33) measures impact of health status of
five domains of the quality of life, has been validated for an
obese population, and is short and easy to use. The visual
analogue scale (EQ-VAS) of perceived health status is simple
to present to a non-specialist audience and was favoured by
the patient participants on the clinical core group.
The primary outcome was weight loss of at least 5% of
initial weight at 1 year. Secondary outcomes were changes
in quality of life, quality of diet, physical activity, blood
pressure, and HbA1c in diabetic patients. Smoking status,
alcohol consumption, newly identified co-morbidities and
referrals were also recorded.
Two hundred and thirty participants were recruited
sequentially (Fig. 3). Two hundred and thirteen were
recruited to the year programme and 17 IFR patients were
admitted for a 6-month intensive programme. The IFR
patients were included in the whole cohort analysis as they
represent the type of patients commonly referred to Tier 3
services nationally, and they received the full intervention,
over a shorter time (Fig. 3). The IFR group differed slightly
in their baseline characteristics with a mean BMI
49.9 kg·m−2 (whole cohort 44.1 kg·m−2), and the IFR group
mean age was 43.6 years (mean age whole cohort 52.7
years).
At the 1-year point, none of the patients referred for
bariatric procedures had been operated on. By 18 months
and 2 years, two IFR patients had undergone bariatric
surgery, but their post-surgical weights were not included
in the analysis to prevent favourably skewing the weight-
loss data.
Completers were defined as those who had completed the
full 1-year programme during the period of the evaluation,
which excluded the 17 IFR patients. The 17 IFR participants
all completed their 6-month programme, and 1-year weight
data was collected on them where possible. The IFR 1-year
and later follow-up weights were included in the analysis of
all with weights recorded, and baseline observation carried
forward (BOCF) analysis (Table 1). Dropouts were defined
as those who had failed to attend two appointments without
explanations, or who declined to attend monthly and been
discharged. All dropouts were contacted by letter or phone
call to confirm their discontinuation.
Follow-up weights post-discharge were obtained from
GP records, or self- reported in response to a written
request (n = 2). Weights were recorded within a month of
the expected attendance date while on the programme, and
for follow-up after discharge a weight within 90 d was
accepted for 18 months and 2-year data.
Statistical analysis
Continuous values in the text and tables are presented as
mean (standard deviation; SD) and categorical data as per-
centage (n =), unless otherwise stated. Differences between
pre- and post-programme measurements were compared by
paired sample t-tests. Therefore, for each comparison, we
only compared those with observations at both time points.
Independent sample t-tests or Pearson χ2 tests were used to
compare characteristics between those recruited to the pro-
gramme and those who were assessed but not recruited.
Data were analysed on an intention-to-treat basis, with the
baseline weight available carried forward when a final
weight was not available (BOCF group). Statistical analyses
were performed using SPSS version 18.0 for Windows
(SPSS Inc., Chicago, IL, USA), and the criterion for statis-
tical significance was P < 0.05.
A focus group was held to explore the experiences of
participants in the service. Participants were recruited by
invitations sent to 50 current participants, purposely chosen
to include participants from different geographic areas, and
who had seen the full range of therapists within the project.
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Ethics committee approval was not required as the NHS
Norfolk research governance team had advised this was a
service evaluation as defined by the National Research
Ethics Service website.
Results
Participant characteristics
In the study period, 1 August 2011 to 1 August 2012, 367
people were referred to FWMS; 18 referrals were rejected
(outside the age or BMI range, requests for post-bariatric
surgery follow-up, or poorly controlled diabetics who
required endocrinology care). Sixty-two people declined to
attend and 57 attended for assessment but were not
recruited. Two hundred and thirty participants were
recruited (Fig. 3).
The 57 who only attended for assessment did not differ
from recruited participants in terms of gender (21% male
vs. 30% male respectively; P = 0.227) or baseline weight
(mean 117 kg vs. mean 124 kg; P = 0.096) or BMI
(42.6 kg·m−2 vs. 44.1 kg·m−2; P = 0.229). However, there
Table 1 Weight changes over time for all participants with recorded weights, all who completed 1-year programme, and all with baseline observation
carried forward
Baseline 3 months 6 months 9 months 12 months 18 months 2 years
Eligible for programme
(n)
230 230 230 230 230 157 84
All with weight
recorded n* (%)
230 218 (95) 195 (85) 149 (65) 170 (74) 96 (61) 45 (54)
Mean weight kg (SD) 124.4 120.8 118.2 116.4 115.8 112.9 112.2
(27.3) (27.0) P < 0.001 (27.4) P < 0.001 (27.2) P < 0.001 (26.0) P < 0.001 (24.9) P < 0.001 (24.8) P = 0.001
Mean weight change
from baseline kg (SD)
– −3.6 −5.8 −8.0 −8.1 −7.1 −5.0
(3.9) (5.6) (7.0) (8.2) (9.5) (9.8)
Mean weight change
from baseline % (SD)
– −3.0 −4.7 −6.5 −6.4 −5.2 −4.3
(2.9) (4.3) (5.5) (6.1) (7.9) (8.2)
≥ 5% weight loss from
baseline n (%)
– 55 86 88 102 46 20
(25.2) (44.1) (59.1) (60) (47.9) (44.4)
≥ 10% weight loss from
baseline n (%)
– 8 24 30 37 26 9
(3.6) (12.3) (20.1) (21.8) (27.1) (20)
All who completed
1-year
programme (117/213)
n (%)
117 117 117 117 117 (51) 58 (37) 29 (35)
Mean weight kg (SD) 125.6 120.8 118.4 116.6 115.5 113.5 113.6
(29.6) (29.2) p < 0.001 (28.8) P < 0.001 (28.5) P < 0.001 (27.8) P < 0.001 (25.6) P < 0.001 (26.5) P = 0.006
Mean weight change
from baseline kg (SD)
– −4.6 −5.8 −8.9 −10.2 −9.6 −5.9
(4.0) (4.3) (7.2) (8.1) (12.8) (10.7)
Mean weight change
from baseline % (SD)
– −3.7 −5.7 −7.1 −8.0 −7.1 −5.1
(3.0) (4.4) (5.5) (6.0) (9.0) (9.1)
≥ 5% weight loss from
baseline n (%)
– 40 63 77 85 35 13
(34.2%) (53.8%) (65.8%) (72.6%) (60.3%) (44.8%)
≥ 10% weight loss from
baseline n (%)
– 7
(6%)
19
(16.2%)
27
(23.1%)
32
(27%)
20
(34.5%)
6
(20.7%)
Baseline observation
carried forward*
230 230 230 230 230 157 84
Mean weight kg (SD) 124.4
(27.3)
120.8 119.3 119.1 118.4 118.0 117.1
(26.8) P < 0.001 (26.6) P < 0.001 (26.8) P < 0.001 (26.4) P < 0.001 (25.8) P < 0.001 (25.6) P = 0.095
Mean weight change
from baseline kg (SD)
– −3.4 −4.9 −5.5 −5.9 −4.7 −2.6
(3.9) (5.6) (6.8) (7.8) (9.7) (7.4)
Mean weight change
from baseline % (SD)
– −2.9 −3.9 −4.2 −4.8 −3.7 −2.3
(2.9) (4.3) (5.4) (5.9) (6.6) (6.3)
≥5% weight loss from
baseline n (%)
– 55 86 88 102 46 20
(23.9) (37.4) (38.3) (44.3) (29.3) (23.9)
≥10% weight loss from
baseline n (%)
– 8 24 30 37 26 9
(3.5) (10.4) (13) (16.1) (16.6) (10.7)
*Includes both 1-year programme and 6-month IFR programme.
SD, standard deviation.
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was a significant difference in age with those recruited
significantly older than those assessed but not recruited
(52.7 years vs. 45.2 years, P = 0.001). There was also a
significant difference in EQ-VAS score with higher scores
(i.e. better self-reported quality of life) for those recruited
(55.7) than those assessed but not recruited (48.6) for the
programme (P = 0.031).
Of the 230 recruited participants, two-thirds of partici-
pants had morbid obesity (BMI of ≥40 kg·m−2) (Table 2).
The commonest co-morbid conditions were hypertension,
depression and diabetes. Seventy per cent of participants
were female, and 82% had less than 19 years of education,
an indicator of lower socioeconomic status. Participants
included non-English speakers, people with learning dis-
ability, and physically handicapped participants who were
expected to be less likely to attend a group intervention. Of
the 230 participants recruited, 229 (99.6%) attended
3-month follow-up, of whom 197 (85.6%) attended
6-month follow-up, and 117 (54.9%) completed the pro-
gramme at 12 months.
Weight loss
Weight values were recorded on 170 patients in total at the
1-year point; completers, IFR follow-up data, plus weights
on those who had dropped out were obtained from medical
records (Table 1).
There were significant reductions in body weight at each
data collection point.
The percentages of the 170 participants with weight
recorded at 12 months who had 5% or greater weight loss
were 25.2, 44.1, 59.1 and 60.0% at 3, 6, 9 and 12 months,
respectively. Of the 117 participants who completed the
year programme (‘completers’), weight losses >5% were
34.2, 53.8, 65.8 and 72.6% at 3, 6, 9 and 12 months. The
mean percentage weight loss at 1 year was –6.4% (SD 6.1)
in the cohort with weights recorded, and –8% (SD 6.0) in
completers.
In a subanalysis of patients with BMI ≥40 kg·m−2, weight
loss was significantly different to baseline at 3 months
(mean weight loss −4.3 [SD 4.2] n = 152), 6 months (mean
weight loss −6.9 [SD 5.9] n = 134), 9 months (mean weight
loss −9.0 [SD 7.4] n = 102) and 12 months (mean weight
loss −9.3 [SD 8.7] n = 116).
All weight data available from 1 August 2011 to 31
December 2013 were analysed. One hundred and fifty-
seven participants were 18 months from initial recruitment,
and 84 were 2 years or more from initial recruitment at the
data analysis point (December 2013). Eighteen-month data
were available for 96 participants, whose mean weight loss
at 18 months was −7.1% (SD 9.5), and of whom 47.9%
maintained a loss of at least 5% of their initial body weight.
At 2 years, data were available for 45 participants, and
mean weight loss was −5 kg with 44.4% maintaining the
5% weight loss (Table 1).
An additional analysis, using the BOCF method to
impute missing values, showed statistically significant
weigh losses from baseline at 1 year and 18 months. At 2
years, the absolute numbers were small, weight loss was
statistically significant in the whole cohort with weight
recorded and completers, but not using BOCF (Table 1).
Secondary outcomes
Participants reported increases in fruit and vegetable con-
sumption and levels of physical activity (Table 3). Mean
physical activity index scores were calculated with higher
scores indicating less activity. Physical activity scores were
reduced significantly at each 3-month data collection point
indicating that participants became more active. Quality of
life increased significantly at each measurement point (indi-
cated by decreased EQ-5D-5L scores). The EQ-VAS scores
increased significantly over the course of the intervention
reflecting participant’s perception of better health
(Table 3). Significant reductions in blood pressure and
HbA1c values in diabetics were also seen between baseline
and 12-month follow-up (Table 3). The secondary outcome
data at 1 year was from the completer group only as the
questionnaires were not posted to patients who had
dropped out.
The service also identified additional pathology in 48
patients: two with hypothyroidism, three with hypercho-
lesterolaemia (total cholesterol >6.5 mmol·L−1), 32 with
Table 2 Baseline characteristics
Characteristic Number Mean (SD)/% Range
Age (years) 230 52.7 (13.6) 18–76
Female 161 (70%)
Weight (kg) 230 124.4 (27.3) 72.4–262.5
BMI (kg·m–2) 230 44.1 (7.8) 30.2–78.6
BMI category
• <35 kg·m−2 29 12.6%
• ≥35 kg·m−2 46 20%
• ≥40 kg·m−2 155 67.4%
Waist circumference (cm) 219* 127.7 (16.3) 85–182
Diabetes 73 31.7%
Impaired fasting glycaemia 1 0.43%
IHD 27 11.7%
Hypertension 88 38.3%
Sleep apnoea 27 11.7%
Depression 72 31.3%
Years of education
• ≤15 years 60 30%
• 15–19 years 104 52%
• ≥19 years 36 18%
*Waist circumference not measured if extreme obesity and
measurements are unreliable.
BMI, body mass index; IHD, Ischaemic heart disease; SD, standard
deviation.
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abnormal liver function, seven with diabetes mellitus, two
with obstructive sleep apnoea, one with hypertension
(blood pressure >160/100 mmHg−1 on three occasions and
requiring antihypertensive medication) and one with
impaired fasting glucose. The incidence of new diabetes
was higher than expected which may reflect the higher
incidence in Norfolk, or the age and BMI range of partici-
pants. The incidence of obstructive sleep apnoea is lower
than expected, and may reflect the screening tools used to
detect it, using oximetry on all the participants might
increase detection rates.
Focus group
The group was attended by three men and nine women.
The group did not include anyone who had seen the psy-
chologist, or dropped out of the programme. The experi-
ences of attenders were very positive. The main reasons for
attending the service were personal health issues:
‘I had breast cancer and heard it was weight related’.
‘I was told I was at risk of becoming diabetic’.
The role of medical staff in raising the issue of obesity
was important in motivating people to join the project.
The NHS brand appeared to add credibility to the
service;
‘I saw the word obesity on my medical screen. . .I was
shocked’.
‘It was medically directed. . .more confident’.
‘Commercial weight loss scheme not interested in my
medical problems’.
The OSNs were described as very important in support-
ing motivation.
‘individual-private and tailored’.
The exercise scheme was highly valued in its own right,
and not just as a tool to achieve weight loss.
‘When I first started I could hardly walk – only 50 yards
– now I can walk 300–400 yards. . .if this project has
done nothing else it has helped me to walk’.
Individual appointments were valued, to allow personal
and confidential discussion, but there was an interest in
setting up a patient run support group to provide long-term
support and motivation. This idea was subsequently devel-
oped and a patient run long-term support group was set up
for those discharged from the project. The venue of the
service was important with most people being prepared to
travel a maximum of 10–15 miles. The time taken to attend
appointments, the difficulty of travel in a rural area and the
cost of travel were all raised as minor barriers to attending.
However, cost was the least important factor, and indeed
some participants stated that they would be prepared to
pay for the service.Ta
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Discussion
The FWMS has demonstrated that a Tier 3 service can be
provided for complex obese patients by a specialist team in
a primary care setting, and was associated with a progres-
sive and substantial reduction in weight at 1 year. The
weight losses achieved of 5% or more of initial weight
could deliver improved health outcomes (20–23). There
was no control group but control groups in randomized
controlled trials of weight-loss interventions have shown
much smaller or no reductions in weight without treatment
(34,35,44), suggesting that these reported changes were at
least partly the effects of FWMS.
Although the aim of 5% of initial weight being lost by
50% of participants at 6 months was not quite achieved
(44.1% whole cohort, 53.8% completers) at 6 months,
within 1 year 60% of the whole cohort or 72.6%
completers had achieved this target. This compares with a
5% loss at 1 year in of 47% of patients in the specialist
multidisciplinary Canadian UETRO service (36) (Table 4),
a group with very similar baseline BMI and interventions.
The 6-month 50% target was challenging with a group
of patients who had mostly tried, and failed with previous
interventions, with a very high baseline mean BMI
(44.1 kg·m−2) and multiple co-morbidities. Two other ser-
vices published results for 5% loss at 6 months in
completers only, (Table 4) RIO 72% (38) and Walsall
57.9% (34), but it was not possible to correct for missing
values or dropouts with the available published informa-
tion, which makes comparison difficult.
The mean weight loss of 10 kg in completers, 5.9 kg
using BOCF analysis and 8.1 kg at 1 year in all those with
weight recorded, compared favourably with the data avail-
able from other services (Table 4). The secondary outcomes
all showed statistically significant improvements, with
improvement in health-related quality of life and diabetic
control being the most clinically relevant. The mean drop in
systolic blood pressure over the year was comparable with
the effect of prescribing an additional antihypertensive
medication. The dietary and activity questionnaires have
limitations discussed in the NOO SEF (29), and in particu-
lar increase in activity was limited in some participants by
extreme obesity and physical disability.
In comparison with the limited published data on Tier 3
services in the UK, FWMS had a relatively low dropout rate
of 45.1% at 1 year. The 6-month rate of 14.3% dropout vs.
51% at RIO (38), and 62.5% Clyde (37) was particularly
striking. The FWMS dropout figures may reflect the con-
venience of a primary-care setting, as well as the design of
the service, with a dedicated administrator, and a choice of
appointment times.
Those with poor motivation may have been deterred
from enrolment at the assessment stage, and by being asked
to sign a contract to attend regularly. The mean age of
those assessed but not recruited was younger than those
who attended. This may reflect competing priorities of
family or employment, but needs to be explored further.
The numbers of participants followed-up at 18 months and
2 years are small, and longer-term follow-up data are
required but the results are encouraging. It is hoped that the
addition of the patient-led long-term support group in
2012 will aid maintenance of weight loss. Although the
NOO SEF is designed to facilitate evaluation and data
comparison, it is not appropriate to compare the FWMS
results with Tier 2 services (45), as the FWMS participants
represent complex or resistant obesity, and many had tried
and failed to lose weight or maintain weight loss prior to
recruitment using Tier 2 services. The FWMS participants
had a mean BMI of 44.1 kg·m−2 which is much higher than
the Counterweight (4) (mean BMI 37.1 kg m−2) or Lighten
Up (40) trials (mean BMI 33.1 kg·m−2 GP subgroup).
Tier 3 services may need additional outcome measures as
absolute or percentage weight loss may not reflect all the
appropriate clinical goals, such as appropriate treatment
before referral to bariatric surgery, improved diabetes
control or detection of undiagnosed co-morbidities such as
obstructive sleep apnoea (6). An agreed co-morbidity
scoring system, such as the Edmonson Obesity Scoring
System (41), might be useful used to describe the popula-
tions attending a service, and allow more accurate com-
parisons between services.
The FWMS was less expensive than secondary care-
based Tier 3 services. It cost between £900 and £1250 per
year for each patient including access to the whole range of
therapists. However, it was more costly than Tier 2 services
such as commercial weight-loss groups (£45–£60 for 12
weeks), or the Counterweight intervention (£100 per
patient per annum).
The service was evaluated from its initial set-up, which
might lead to an underestimate of its eventual effectiveness.
The first 6 months included extensive additional staff train-
ing, and the gym was unavailable till January 2012. The
patient follow-on support group was available from mid-
2012 onwards. Less orlistat was prescribed than expected
as there was a national shortage of the drug during this
period. The availability of bariatric surgery was limited by
the NHS East of England guidelines, which were more
restrictive than NICE guidelines. Only nine patients were
started on LELDs during this period, but the numbers are
now increasing as evidence emerges of their safety and
efficacy in primary care (42,43).
In view of the increasing prevalence of obesity, there is
need for more research on the cost-effectiveness of weight
management services for complex obese patients in a both
primary and secondary care (6). Further research is needed
to evaluate this programme in other locations, and with a
control group. The FWMS is one model of how a Tier 3
service can be delivered in a primary-care setting, and
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achieve comparable results to published interventions in
similar populations.
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